NHS Greater Glasgow and Clyde Recommends EMIS Software for 243 GPASS Practices

EMIS Group plc (AIM: EMIS), the UK's leading supplier of healthcare software and related services to GPs, announces that NHS Greater Glasgow and Clyde has recommended EMIS software to replace the GPASS system used by 243 of its GP practices. The agreement is worth approximately £1m to EMIS in core annualised revenues.

NHS Scotland set out its eHealth Strategy 2008 - 2011 to replace the current GP System (GPASS) used by 683 practices across Scotland as part of a broader programme of support for improving eHealth in primary and community care. The market in Scotland has since opened up to competition with the objective to replace the existing system by March 2012.

Glasgow and Clyde is Scotland's largest health board with 269 GP practices, of which 243 currently use GPASS. Deployment of EMIS software will commence shortly at the Glasgow sites, with the full impact of the contract taking effect during 2011 onwards.

In January 2010, EMIS was selected by NHS National Services Scotland as one of only two companies to receive preferred bidder status and in the past few months the Company has undergone a robust tendering process with the health boards.

Prior to the formal notification of EMIS preferred bidder status, 51 GP practices within the Ayrshire and Arran Health Board had already chosen EMIS to replace its existing software. It is expected that other health boards will reach their decisions in the coming months.

Sean Riddell, Chief Executive of the Group, said: "This is excellent news for EMIS. As we outlined at the time of our IPO, Scotland represents a key growth market for the Company. As Scotland's largest health board, the Glasgow & Clyde contract makes up a significant proportion of that opportunity.

"We believe that EMIS' user-friendly format, advanced functionality and competitive pricing position us well for further growth in Scotland and we look forward to reporting additional successes in other parts of the country as the results of the tendering process are announced."

Anout EMIS Group
EMIS Group is the UK's leading supplier of software and related services to GP practices, with approximately 39 million patient records in the UK held on EMIS' software.

Established in 1987, EMIS' core activities include software licensing and support, hardware support and maintenance services, hardware sales, third party software sales and training services.

The Group's software includes all of the functionality specified in NHS accreditation standards for GPs, including holding the patient's cradle to grave electronic healthcare record, practice appointment booking systems and consultation and intelligent prescribing modules.

EMIS Web represents the next generation of clinical software systems and the Directors believe it has the potential to transform the delivery of healthcare by enabling GPs and other healthcare practitioners to connect with each other and securely share access to a patient's cradle to grave electronic health record.

For more information, visit www.emis-online.com.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...